When compared to the empty vector-transduced NK-92MI cells, these reprogrammed NK-92MI cells showed significantly increased CD107a expression and production of granzyme B, IFN- against CD138-positive human MM cell lines (RPMI8226, U266, and NCI-H929). This evidence concerns the gene IFNA1 and Miyoshi myopathy.